(Q45360478)

13 December 2017

title

IL28B rs12979860 polymorphism does not influence outcomes of hepatitis B virus infection (English)

1 reference

13 December 2017

1 reference

L J Peng

1

1 reference

13 December 2017

J S Guo

2

1 reference

13 December 2017

Z Zhang

3

1 reference

13 December 2017

H Shi

4

1 reference

13 December 2017

J Wang

5

1 reference

13 December 2017

J Y Wang

6

1 reference

13 December 2017

publication date

13 January 2012

1 reference

13 December 2017

1 reference

13 December 2017

volume

79

1 reference

13 December 2017

issue

4

1 reference

13 December 2017

page(s)

302-305

1 reference

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2011.01835.X

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2011.01835.X

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2011.01835.X

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2011.01835.X

A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2011.01835.X

Interleukin-28B genetic variants and hepatitis virus infection by different viral genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2011.01835.X

Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2011.01835.X

Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2011.01835.X

IL-28, IL-29 and their class II cytokine receptor IL-28R

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2011.01835.X

Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2011.01835.X

Epidemiology of hepatitis B virus infection in the Asia-Pacific region

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2011.01835.X

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2011.01835.X

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2011.01835.X

IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2011.01835.X

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2011.01835.X

Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2011.01835.X

Effect of interferon-lambda on replication of hepatitis B virus in human hepatoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2011.01835.X

Lambda and alpha interferons inhibit hepatitis B virus replication through a common molecular mechanism but with different in vivo activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2011.01835.X

Clinical significance of a set of single nucleotide polymorphisms of hepatitis B virus core gene in Chinese Han patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2011.01835.X

IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: Role in the course of chronic viral hepatitis and the development of HCC

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2011.01835.X

10.1111/J.1399-0039.2011.01835.X

21 January 2018

Identifiers

DOI

1 reference

13 December 2017

1 reference